![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMEDG RNS Number : 7769B Medgenics Inc 02 November 2009 Medgenics, Inc. ('Medgenics' or the 'Company') 2 November 2009 The Board of Medgenics announces that on 30 October 2009 Mr. Joel Kanter (a Director of the Company) informed the Company that on 30 October he acquired in the market 25,000 common shares of par value US$ 0.0001 each ("Common Shares") in the Company at a price of 9.2 pence per Common Share. The total interest in Shares of Mr. Kanter and his related parties following this purchase is 14,078,397 Common Shares representing approximately 11.5 % of the issued share capital of the Company (excluding his interest in warrants, options and convertible debentures as previously announced). For further information, contact: +----------------------------------------------------+---------------------------------------+ | Medgenics, Inc. | Phone: +972 4 902 8900 | | Dr. Andrew L. Pearlman | | | | | +----------------------------------------------------+---------------------------------------+ | Grayling (Financial PR, UK) | Phone: +44 7900 053 536 | | Jonathan Shillington | jonathan.shillington@uk.grayling.com | | Alistair Scott | | | | | +----------------------------------------------------+---------------------------------------+ | Blomfield Corporate Finance Limited (Nominated | Phone: +44 207 444 0800 | | Adviser) | | | James Pinner | | | Alan MacKenzie | | | | | +----------------------------------------------------+---------------------------------------+ | SVS Securities plc (Broker) | Phone: +44 207 638 5600 | | Ian Callaway | | | | | +----------------------------------------------------+---------------------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END RDSEAAFAEFPNFFE
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions